A research agenda for curing chronic hepatitis B virus infection
Journal
Hepatology
Journal Volume
67
Journal Issue
3
Pages
1127-1131
Date Issued
2018
Author(s)
Alter H.
Block T.
Brown N.
Brownstein A.
Brosgart C.
Chang K.-M.
Chisari F.V.
Cohen C.
El-Serag H.
Feld J.
Gish R.
Glenn J.
Greten T.
Guo H.
Guo J.-T.
Hoshida Y.
Hu J.
Kowdley K.V.
Li W.
Liang J.
Locarnini S.
Lok A.S.
Mason W.
McMahon B.
Mehta A.
Perrillo R.
Revill P.
Rice C.M.
Rinaudo J.
Schinazi R.
Seeger C.
Shetty K.
Tavis J.
Zoulim F.
SDGs
Other Subjects
antivirus agent; neutralizing antibody; antivirus agent; virus DNA; antiviral therapy; Article; chronic hepatitis B; cytotoxic T lymphocyte; DNA virus; Hepatitis B virus; human; liver cell carcinoma; morbidity; mortality; nonhuman; priority journal; T lymphocyte; T lymphocyte activation; virogenesis; virus genome; chronic hepatitis B; drug development; drug effect; genetics; medical research; procedures; virology; Antiviral Agents; Biomedical Research; DNA, Viral; Drug Discovery; Hepatitis B virus; Hepatitis B, Chronic; Humans
Publisher
John Wiley and Sons Inc.
Type
journal article